新闻

最新消息


Cancer drugmaker ArriVent follows on CG’s heels with $175M IPO

Yahoo! Finance

1月 26日, 2024
Cancer drug developer CG Oncology valued at $1.75B in strong IPO debut

Reuters

1月 25日, 2024
Synnovation Therapeutics Launches with $102M Series A Funding

Businesswire

1月 24日, 2024
有兴趣和我们联系
联系我们